Lactate Clearance According to the Presence of Hepatic Dysfunction
NCT01709565 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 245
Last updated 2012-10-18
Summary
The purpose of this study is to compare lactate clearance in patients with severe sepsis and septic shock according to the presence of hepatic dysfunction.
Conditions
- Sepsis
- Liver Failure
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Principal Investigators
-
Ik Joon Jo, PhD · Samsung Medical Center
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
The Prognostic Value of Lactate is Different Among Septic Patients
NCT04155060 ·Status: COMPLETED
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients
NCT06256198 ·Status: NOT_YET_RECRUITING
-
Temporal Changes of Lactate in CLASSIC Patients
NCT05629780 ·Status: COMPLETED ·Phase: NA
-
Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock
NCT01310790 ·Status: COMPLETED ·Phase: PHASE4
-
Investigate the Activity of Endotoxin in Severe Sepsis
NCT01957254 ·Status: TERMINATED
-
Repository for Sepsis and Postresuscitation Samples
NCT01670383 ·Status: RECRUITING
-
Lactate Kinetics in Septic Shock
NCT05349370 ·Status: RECRUITING ·Phase: NA
-
Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock
NCT00159952 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Microcirculatory Oxygen Uptake in Sepsis
NCT02430142 ·Status: COMPLETED
-
Severe Sepsis and Septic Shock Registry
NCT02936232 ·Status: RECRUITING
-
Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic Control
NCT01013662 ·Status: COMPLETED ·Phase: NA
-
4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock
NCT01211899 ·Status: UNKNOWN
-
Optimization of PK/PD Target Attainment for Meropenem in Critically Ill Patients With Sepsis
NCT03560557 ·Status: COMPLETED
-
Serial Body Composition Change for Risk Prediction and Nutritional Guide in Treating Patients With Sepsis
NCT04989569 ·Status: COMPLETED ·Phase: NA
-
Quantification of Dilutional Anemia in the Initial Phase of Sepsis Management: Preliminary Retrospective Study
NCT06242561 ·Status: COMPLETED
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation
NCT01362829 ·Status: COMPLETED
-
Transfusion-requirements in Septic Shock Trial
NCT01485315 ·Status: COMPLETED ·Phase: PHASE3
-
Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis
NCT00541827 ·Status: COMPLETED
-
Ratio of ''Central Venous-to-Arterial Co2 Gap'' to ''Arterial-to-Central Venous O2 Content Gap'' in Septic Shock
NCT04425161 ·Status: UNKNOWN
-
Saving Lives by Early Detection and Treatment of Sepsis and Septic Shock by Point of Care Lactate Test in Adults
NCT05108467 ·Status: UNKNOWN
-
Muscle Lactate and Lactate to Pyruvate Ratio Clearance in Septic Shock Patients
NCT03700346 ·Status: COMPLETED ·Phase: NA
-
Alpha-lipoic Acid in Critically Ill Patients With Sepsis
NCT06661993 ·Status: COMPLETED ·Phase: NA
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA